Single domain antibodies: promising experimental and therapeutic tools in infection and immunity - Wikidata - thesis-toulmin - TriplyDB

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

http://www.wikidata.org/entity/Q28248678

about

Heterologous antigen selection of camelid heavy chain single domain antibodies against tetrabromobisphenol A Intracellular activation of interferon regulatory factor-1 by nanobodies to the multifunctional (Mf1) domain Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region Crystal Structure of a Human Single Domain Antibody Dimer Formed through VH-VH Non-Covalent Interactions Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus Directed Evolution of Human Heavy Chain Variable Domain (VH) Using In Vivo Protein Fitness Filter Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain VHH antibodies: emerging reagents for the analysis of environmental chemicals Engineered single-domain antibodies with high protease resistance and thermal stability High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain A nanobody:GFP bacterial platform that enables functional enzyme display and easy quantification of display capacity Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.Nanobody: the "magic bullet" for molecular imaging?A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry The availability of a recombinant anti-SNAP antibody in VHH format amplifies the application flexibility of SNAP-tagged proteins.Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein.Direct injection of functional single-domain antibodies from E. coli into human cells.ADP-ribosylation of arginine.Isolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus enterotoxin B.Development and utilization of camelid VHH antibodies from alpaca for 2,2',4,4'-tetrabrominated diphenyl ether detection.Llama-derived single domain antibodies specific for Abrus agglutinin.A V(L) single-domain antibody library shows a high-propensity to yield non-aggregating binders.Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage Variants A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo.Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures

P2860

Q23914851-8643366A-6D9D-4D85-953D-D07A19510392 Q24634375-BE17B736-1630-473B-A2CA-2E44A61CB78C Q26738678-0DB38B43-EE96-4B78-979A-63D97350D9F6 Q26991574-284E9F03-4A15-471E-B49D-8D304ED17157 Q27006383-F2539DAD-7B99-4B61-8D1A-B0FE82E69F7B Q27303580-83E78FBB-12C5-4309-B69E-870A082C645D Q27659624-64B10F92-0A04-4A0D-94FC-5795DFBA6A73 Q27676789-48134224-F932-41E0-B5A4-624C8AFAB7B8 Q27677883-57DB97EF-E4E6-4041-89A4-E6F8C453F524 Q27683156-2E105451-7D17-43D7-8E32-95F7692311D7 Q27684059-47D0EE3B-8643-4DE1-8085-121D5E5953D7 Q28302768-79371BC1-811E-46DB-9118-27D3FF51EC2F Q28386514-EA14568F-87DB-4938-BAB3-9984847605DF Q28478199-21A5DF0E-ACCA-4972-995B-0AF0BF072B10 Q28480982-ED290CA0-F186-475E-84E1-0AF7CEDFDA33 Q28603328-05976C47-9BF4-4A72-8D13-C9CDDAFFA2FC Q28744316-A02D467D-1D24-45E0-8159-CC2A841AB48E Q30153481-FDB3C79F-266D-46C1-837F-84958BB2688A Q30372369-F2D230A2-5D3A-4802-85CD-4763D473F467 Q30413694-85E0D906-F04A-4FC7-B5DD-D48B3FF0A6C5 Q30442626-C9F0629A-0CD1-4D9B-8BBE-A06D01EC0AA0 Q33410645-5380B7D0-2AC6-40F9-953C-50725A76EDF0 Q33526251-DA0EC603-F1F2-4EAD-905E-8CFA639CA2B6 Q33617935-1BF7463C-D7E4-4983-8203-CCBA2CD06AD3 Q33653646-A1107A6B-096B-4CC0-B344-F75CE3FA84AE Q33688370-17DAA457-B26D-4A85-A74C-FE25BF2B35D1 Q33730217-24B55FB2-C988-425D-AAE3-2367DC38DB64 Q33764318-0B72CD21-7F33-4EBF-BF3D-4913890E607D Q33775617-B9482E8C-1114-4950-AB7E-72F6A7BD5E7C Q34023226-698596A5-9040-44F6-B652-8803914DAFFB Q34024718-C2EAEC00-F1F1-431D-8431-021D39CC5FB0 Q34089104-DC2372D7-5029-4D0F-861A-41F36AEA3646 Q34103619-18320965-E2E8-448E-8605-8877384927A3 Q34227317-ABDAD66C-8864-485E-8C39-CBAC7D6D9A61 Q34287684-9480D01B-BCF9-4794-B83C-ADC6BF5AFD98 Q34315655-DAD896BB-6932-4B49-8548-BE59B4167599 Q34407012-92EA4F8E-F443-4B7A-9A55-5D619AEBC81A Q34408085-AB172EAF-947C-4F3B-8296-1C2A406B93F6 Q34470605-9F6AC018-BE72-4DF9-86B6-EB163CA0EA66 Q34476404-925AE40A-A59E-4F82-9D8F-DB455432C07C

P2860

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

http://www.wikidata.org/entity/Q28248678

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Single domain antibodies: prom ...... ools in infection and immunity

@ast

Single domain antibodies: prom ...... ools in infection and immunity

@en

Single domain antibodies: prom ...... ools in infection and immunity

@nl

type

label

Single domain antibodies: prom ...... ools in infection and immunity

@ast

Single domain antibodies: prom ...... ools in infection and immunity

@en

Single domain antibodies: prom ...... ools in infection and immunity

@nl

prefLabel

Single domain antibodies: prom ...... ools in infection and immunity

@ast

Single domain antibodies: prom ...... ools in infection and immunity

@en

Single domain antibodies: prom ...... ools in infection and immunity

@nl

P1433

Q28248678-2639B815-53BF-404F-AA2F-C9EEC3D06B86

P1476

Q28248678-BE79B458-FAB4-4849-B556-60F1AC28F7AE

P2093

Q28248678-03AD6241-ED4C-4269-BCE8-22E2842E8310

Q28248678-15585BEA-5A7D-48AC-8E09-07BD5A9C62E6

Q28248678-17C22D5E-E3D3-42C2-8E1E-CC06FB755783

Q28248678-1802CAE9-F33B-45F5-B00B-2EE268147EFF

Q28248678-55AFEC8D-A1D9-45A3-BB47-5E5BC02517BE

Q28248678-60E35D78-F52F-43FB-9519-8D04036BBB0F

Q28248678-65870119-F940-4B7A-A4D0-FB0A1062FBCD

Q28248678-94B3A0C0-ED9B-4541-A008-ADCA0CD21FC8

Q28248678-CF58F05D-7A25-4336-B39B-743DD399CF95

Q28248678-D8910977-F24F-4781-B1FE-ABD32666F06E

P2860

Q28248678-01F51C8D-10D2-40DD-976C-D3F951FC22EF

Q28248678-02314B1C-8776-447F-9E83-6F87CBF5C192

Q28248678-0261211A-D7C1-493C-9CD6-63E6DAC78A33

Q28248678-03DBE42B-6B83-420D-861F-536F840027AA

Q28248678-09BAF32F-DB78-4B19-9BC3-1D437739E52A

Q28248678-0A61F649-A1C4-4C3C-8C93-2B168E959528

Q28248678-0AB54C66-7B08-4921-8099-05E4DF13E909

Q28248678-0BBAFB6D-9B42-4CAD-9678-760DEFE868B1

Q28248678-0CE5382D-11F3-4299-926C-553568A88E84

Q28248678-0EE138CB-909A-4F8E-AEA6-524F3C2E5069

P2888

Q28248678-8BC57073-2147-43EA-8B0E-C2FCC10F7A56

P304

Q28248678-4EE437FB-BE11-4AF5-9D8F-6F9110AC1E3B

P31

Q28248678-E2F9F2A1-2A69-4226-980D-6FF3F1D67371

Q28248678-F3A47A0A-E7F2-4215-98A4-DE2AA9E748BD

P3181

Q28248678-AFD7C0BC-70EC-4ED9-A643-22A8E010034F

P356

Q28248678-21F9451A-DF35-49B9-93F6-05215332449A

P407

Q28248678-80FB964A-807A-47B8-92E2-DE4CF47BC14E

P433

Q28248678-FA33F0C9-908F-43BA-92E1-150DD30A6B02

P478

Q28248678-8D3C7C86-D825-406D-971E-366A87CAC414

P50

Q28248678-197C3E9D-F32F-480C-95AF-B2E130F59867

Q28248678-312C7DD0-684A-41F4-B8C1-C12E9378D444

Q28248678-5BE3E7CA-89F5-4ED6-AC87-AF2423B4D0E1

Q28248678-623F3D4B-BDDB-4E04-BCB1-FE40B75B061B

Q28248678-676E2470-7CC5-4B41-8FFC-4E68292BBD79

Q28248678-AC53BA86-58BD-4819-9B39-CFFBC462D096

Q28248678-AE993E2C-EBE1-4B92-AFBE-36FD7DBF87A8

Q28248678-B7C878ED-2542-4CB0-B8A9-5C4F9AEF4CF5

Q28248678-DEAA84A3-1D4B-47BC-B77C-3A380A560A66

Q28248678-EFDCA9E7-A209-4F67-AC4D-F60525ECE5B3

P577

Q28248678-76A16EDC-5C51-4DF5-AB09-C8B7E53A00BC

Q28248678-A85A908E-B08F-42F2-A4A0-F3B3A3A1FE36

P5875

Q28248678-0676CFBD-1850-47CA-BF7D-14AABC2C20BD

P6179

Q28248678-D22224E5-E040-4D7B-B9F2-6A399F16C67E

P698

Q28248678-208AAA82-1DBD-4FB9-AD03-EEA1F4C925EE

P921

Q28248678-7A371062-A57D-4CCE-B6E6-31278F5F132E

Q28248678-7C1BEFDA-535B-4C51-A525-C9B48A3781DB

Q28248678-B576D283-1E0F-42B7-8680-B0D2F7A9B01B

P932

Q28248678-2A080549-E63E-4E25-BF50-2270D758E451

P3181

P356

S00430-009-0116-7

P1433

Medical Microbiology and Immunology

P1476

Single domain antibodies: prom ...... ools in infection and immunity

@en

P2093

Ana Cauerhff

http://www.w3.org/2001/XMLSchema#string

David V Serreze

http://www.w3.org/2001/XMLSchema#string

Friedrich Haag

http://www.w3.org/2001/XMLSchema#string

Jan Reyelt

http://www.w3.org/2001/XMLSchema#string

Janusz Wesolowski

http://www.w3.org/2001/XMLSchema#string

Karla Juarez

http://www.w3.org/2001/XMLSchema#string

Mandy Unger

http://www.w3.org/2001/XMLSchema#string

Mariela Urrutia

http://www.w3.org/2001/XMLSchema#string

Michel Seman

http://www.w3.org/2001/XMLSchema#string

Nicole Schwarz

http://www.w3.org/2001/XMLSchema#string

P2860

Functional aspects of protein mono-ADP-ribosylation

Properties, production, and applications of camelid single-domain antibody fragments

Camelid heavy-chain variable domains provide efficient combining sites to haptens

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme

Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus

Crystal Structure of the N-Terminal Domain of the Secretin GspD from ETEC Determined with the Assistance of a Nanobody

Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1

P2888

s00430-009-0116-7

P304

157-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1897081

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00430-009-0116-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Friedrich Koch-Nolte

Felix Scheuplein

Welbeck Danquah

Vanina Alzogaray

Mariela Urrutia

Alexei Licea-Navarro

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26295283

http://www.w3.org/2001/XMLSchema#string

P6179

1038200468

http://www.w3.org/2001/XMLSchema#string

P698

19529959

http://www.w3.org/2001/XMLSchema#string

P921

P932

2714450

http://www.w3.org/2001/XMLSchema#string